Schering-Plough Posaconazole NDA User Fee Date Is March 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
Potential spring launch of invasive fungal infection agent Noxafil could be Schering’s next new product after Vytorin; the Zetia/Zocor combination’s user fee date is July 24. Schering’s remaining NME in Phase III is another anti-infective.